Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ | 19,897 | reported | 30 Nov 2022 | tx 8+426,000−6,103 |
| Viridian Therapeutics, Inc.\DE | 16,409 | reported | 03 Mar 2026 | tx 10+964,109−15,595 |
| Kiniksa Pharmaceuticals International, plc | 5,855 | reported | 20 Mar 2021 | tx 26+728,230−464,134 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Mar 2026 | EXERCISE | Viridian Therapeutics, Inc.\DE | 9,409 | — | |
| 03 Mar 2026 | TAX_WITHHOLDING | Viridian Therapeutics, Inc.\DE | 3,138 | 29.32 USD | |
| 03 Mar 2026 | EXERCISE | Viridian Therapeutics, Inc.\DE | 9,409 | 0.00 USD | deriv |
| 02 Mar 2026 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 35,300 | 0.00 USD | deriv |
| 02 Mar 2026 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 176,550 | 0.00 USD | deriv |
| 03 Mar 2025 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 225,814 | 0.00 USD | deriv |
| 03 Mar 2025 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 37,636 | 0.00 USD | deriv |
| 27 Sept 2024 | PURCHASE | Viridian Therapeutics, Inc.\DE | 5,000 | 23.41 USD | first after silence |
| 30 Oct 2023 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 474,400 | 0.00 USD | deriv |
| 30 Nov 2022 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 3,000 | 0.94 USD | |
| 01 Aug 2022 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 75,000 | 0.00 USD | deriv |
| 31 May 2022 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 3,000 | 0.99 USD | |
| 17 May 2022 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 50,000 | 0.00 USD | deriv |
| 15 Feb 2022 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 75,000 | 0.00 USD | deriv |
| 16 Sept 2021 | SALE | Dianthus Therapeutics, Inc. /DE/ | 6,103 | 6.73 USD | |
| 14 Sept 2021 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 20,000 | 0.00 USD | |
| 14 Jun 2021 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 200,000 | 0.00 USD | deriv |
| 20 Mar 2021 | GRANT_AWARD | Kiniksa Pharmaceuticals International, plc | 5,855 | 0.00 USD | deriv |
| 20 Mar 2021 | GRANT_AWARD | Kiniksa Pharmaceuticals International, plc | 4,287 | 0.00 USD | deriv |
| 16 Mar 2021 | GRANT_AWARD | Kiniksa Pharmaceuticals International, plc | 8,769 | 0.00 USD | deriv |
| 16 Mar 2021 | GRANT_AWARD | Kiniksa Pharmaceuticals International, plc | 52,611 | 0.00 USD | deriv |
| 03 Feb 2021 | SALE | Kiniksa Pharmaceuticals International, plc | 2,477 | 22.09 USD | |
| 03 Feb 2021 | CONVERSION | Kiniksa Pharmaceuticals International, plc | 300,000 | — | |
| 03 Feb 2021 | CONVERSION | Kiniksa Pharmaceuticals International, plc | 300,000 | 0.00 USD | deriv |
| 10 Sept 2020 | GRANT_AWARD | Kiniksa Pharmaceuticals International, plc | 75,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 27 Sept 2024.